IREDA FY26 results: profit up, NPAs rise as loans jump

IREDA’s FY26 numbers and the related social media discussion are being driven by a simple split: strong balance sheet growth and capital metrics, alongside visible pressure on asset quality and quarterly profitability.

FY26 headline result: profit up, revenue stronger

IREDA reported a 10 percent year-on-year rise in consolidated net profit for FY26. Consolidated profit after tax came in at ₹1,874 crore, up from ₹1,698 crore in FY25. Total revenue from operations rose 23 percent to ₹8,310 crore from ₹6,743 crore. Interest income increased 24 percent to ₹8,180 crore versus ₹6,576 crore a year earlier. Profit before tax rose 11 percent to ₹2,338 crore from ₹2,104 crore. Earnings per share improved to ₹6.73 from ₹6.32. Total comprehensive income was ₹1,997 crore compared with ₹1,767 crore. The broad takeaway being discussed is that growth in interest income stayed strong through FY26.

FY26 audited numbers at a glance

The audited FY26 print is being circulated alongside a few key comparatives from FY25. These figures help explain why the stock is being debated as both a growth lender and a risk-monitoring story. Investors are focusing on the spread between fast loan growth and higher impairment provisions. Another point being tracked is the relationship between revenue growth and profit growth. Revenue expanded faster than profit, which invites questions on costs, credit, and margins. The table below captures the most repeated audited consolidated metrics. It is also consistent with the narrative of higher disbursements and a bigger book. The same dataset is being used to anchor dividend and capital discussions.

Loan book growth: expansion remains the core story

IREDA’s loan assets at amortised cost rose to ₹92,896 crore as of March 31, 2026, from ₹76,178 crore a year earlier. Separately, provisional disclosures referenced an outstanding loan book of about ₹93,075 crore at year-end, up around 22 percent. Provisional FY26 loan disbursements were reported at ₹34,946 crore, up 16 percent from ₹30,169 crore in FY25. Provisional annual loan sanctions were reported at ₹51,883 crore, described as the company’s highest ever. Social media commentary has leaned on these operational prints to argue the growth engine is intact. The same posts also note that this scale-up is happening even as quarterly profitability became choppier late in the year. For market participants, the key question becomes whether growth and credit costs can stay in balance. The debate is also influenced by IREDA’s role as a government enterprise under MNRE, which shapes expectations around renewable financing demand.

Asset quality watch: Gross NPA and provisioning trends

Alongside growth, asset quality is the major counterpoint in the discussion. Reports cited gross NPA at 3.49 percent in FY26 versus 2.45 percent in FY25. Provisions for impairment on financial instruments were also highlighted as rising sharply to ₹777 crore in FY26 from ₹237 crore in FY25. IREDA reported an impairment allowance, or ECL, of ₹2,689 crore on the loan portfolio, aligned with Ind AS 109. These items are being read as a sign of more conservative recognition as the book grows, but also as evidence of stress in parts of the portfolio. The market tends to react more to the direction of credit indicators than to one-year levels. For analysts, the important follow-through will be whether the higher provisioning rate stabilises. Many retail investors are also trying to reconcile fast disbursement growth with a higher NPA ratio. The net result is a narrative where growth is not in doubt, but underwriting and monitoring are under closer scrutiny.

Capital adequacy: CRAR improves after RWA reduction

Capital strength became a talking point because of a reported improvement in CRAR. Early adoption led to a reduction in risk-weighted assets by ₹7,788 crore and increased CRAR by 1.83 percent. As a result, CRAR improved to 20.59 percent as on March 31, 2026, compared with 17.77 percent in the previous year. Tier I CRAR stood at 18.41 percent and Tier II CRAR at 2.18 percent. Investors discussing lenders often use CRAR as a quick check on growth capacity. Higher CRAR can support future lending without immediate dilution, assuming asset quality remains manageable. The RWA movement is also relevant because it can change perceived risk intensity of the balance sheet. This is why the CRAR improvement is being mentioned alongside loan book expansion. The market will still look for clarity on how much of the improvement is structural versus accounting and timing.

QIP and net worth: equity raise adds another layer

IREDA also raised equity through a qualified institutional placement during the year. It issued 12.14 crore equity shares at a premium of ₹155.14 per share, aggregating to ₹2,006 crore. This capital raise is being tied to the lender’s ability to keep growing disbursements. Another circulated metric is net worth, which was cited as increasing 34 percent to ₹13,781 crore in FY26. Together, the QIP and net worth growth are being framed as balance sheet strengthening steps. For investors, dilution concerns are usually weighed against the benefits of added capital for growth. The pricing and size of the QIP are being used to infer institutional appetite at the time of issuance. In discussions, the QIP is also being linked to CRAR and the pace of loan growth. Some posts also compare capital actions with quarterly margin trends, suggesting profitability needs to keep pace with scale. Overall, the capital story is supportive, but it does not fully offset concerns on credit costs.

Quarter-by-quarter signals: strong Q2 and Q3, softer Q4

The FY26 annual result sits on top of a mixed quarterly pattern that drew attention online. Q3 FY26 was described as strong, with standalone profit after tax at ₹585 crore, up 37 percent year-on-year, and revenue from operations at ₹2,130 crore, up 26 percent. Q2 FY26 was also presented as robust, with consolidated net profit at ₹549.33 crore and interest income at ₹2,057.28 crore. In Q2, NII was cited at ₹817 crore and profit before tax at ₹696 crore, and PAT margin was cited at 26.70 percent. However, Q4 was discussed as a slowdown phase where interest income still grew to ₹2,175.33 crore, but net profit slipped to ₹492.63 crore from ₹585.16 crore in the previous quarter. Another widely shared datapoint was the contraction in net interest margin from 34.33 percent in Q3 FY26 to 29.17 percent in Q4 FY26. This combination explains why people describe FY26 as a strong year with a weaker finish. The practical investor question is whether Q4 was a one-off margin and provision spike or the start of a new trend.

Dividend and audit flags: what is being debated

The board approved the audited consolidated financial statements and recommended a final dividend for FY26. One set of reports cited a final dividend recommendation of ₹0.75 per share. At the same time, the auditor flagged key matters that became part of the social media debate. These included the temporary absence of an audit committee and the classification of certain loan accounts. Investors generally treat such flags differently from quantified financial metrics, but they can affect confidence. The audit committee point is being discussed mainly as a governance and process issue. The loan classification point is being watched because it can intersect with reported NPAs and provisioning. Market conversations are also separating headline profit growth from these qualitative disclosures. The dividend conversation is straightforward, but it is being framed alongside questions about sustaining profitability. In short, the FY26 result generated both a shareholder-return headline and a governance checklist.

What to track next based on FY26 disclosures

The next phase of discussion is likely to revolve around three levers: growth, margins, and credit costs. On growth, watchers will track whether sanctions and disbursements stay near FY26’s provisional levels. On margins, the focus will remain on whether the Q4 net interest margin compression persists or reverses. On asset quality, gross NPA movement and the pace of provisions will matter more than one-time annual profit prints. Investors will also watch how the ECL framework and account classification play out in future disclosures. Capital adequacy is currently a supportive datapoint, with CRAR at 20.59 percent, but it can change with growth and risk weights. The dividend recommendation adds to the total return narrative, but it does not remove the need to monitor risk. For many market participants, IREDA remains a clean energy financing proxy, with FY26 showing both scale and the costs that can accompany scale. The clearest FY26 lesson from the numbers is that loan expansion is strong, but the market is no longer treating that as the only variable.